From Bench to Bedside: The Biomarkers of Aging Bottleneck with Dr. Chiara Herzog

Welcome back to Decoding Longevity! This week, we’re joined by Dr. Chiara Herzog, a molecular biologist and aging researcher at King’s College London, for a conversation about why the aging clocks we’ve built aren’t ready for your annual checkup just yet. Despite impressive progress in biological aging measurement—from DNA methylation clocks to blood-based biomarkers—most of these tools remain stuck in the lab. So what’s stopping them from reaching the clinic? In this episode, we explore: The translational challenges in the field of aging biomarkers Issues around standardization, reproducibility, and data access Why we need large-scale, public aging cohorts Dr. Herzog’s top recommendations for accelerating clinical translation Her long-term vision for integrating aging biomarkers into healthcare 🎧 This is also a special milestone episode for us—Dr. Herzog is our first female guest, and we’re thrilled to spotlight her vital voice in geroscience. 🔗 Show notes & Dr. Herzog’s publications: https://www.nature.com/articles/s43587-024-00683-3 📍 Subscribe for more conversations at the edge of aging science & healthspan innovation. 📣 Hosted by Dr. Raghav Sehgal & Dr. Macsue Jaques #DecodingLongevity #ChiaraHerzog #AgingBiomarkers #TranslationalScience #LongevityScience #EpigeneticClocks #WomenInSTEM #Gerontology #biologicalage